Journal of Clinical & Experimental Neuroimmunology
Open Access

Research Article

International Consensus: Paraneoplastic Neurological Antibodies - are we there yet?

Abid Karim^1,3*, William Egner², Dina Patel², Alex Richter^1,3 and Saiju Jacob^1,3

¹Neuroimmunology, Clinical Immunology Service, University of Birmingham, Birmingham, B15 2TT, UK

²UK NEQAS Immunology, Immunochemistry & Allergy, Northern General Hospital, Herries Road, Sheffield, S5 7AU, UK

³Queen Elizabeth Neurosciences Centre, University Hospital Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK

*Corresponding Author:

Abid Karim
Neuroimmunology, Clinical Immunology Service
University of Birmingham, Birmingham, B15 2TT, UK
Tel: +44 (0)121 415
E-mail: a.r.karim@bham.ac.uk

Received date: Jan 08, 2016; Accepted date: Mar 18, 2016; Published date: Mar 22, 2016

Citation: Karim A, Egner W, Patel D, Richter A, Jacob S (2016) International Consensus: Paraneoplastic Neurological Antibodies - are we there yet?. J Clin Exp Neuroimmunol 1:105. doi: 10.4172/jceni.1000105

Copyright: © 2016 Karim A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

A survey amongst the participants of the Paraneoplastic Neurological Antibody Scheme, registered with United Kingdom National External Quality Assessment Service (UK NEQAS), across the UK, continental Europe and non- European countries examined various factors involved in the laboratory diagnostic methodologies, timely provision of results and a snapshot of External Quality Assessment (EQA) performance to ascertain the level of harmonisation amongst participating laboratories. Despite variations in some aspects of the analytical methods there appears to be a good agreement in the outcome of the results as demonstrated by the EQA performance.

Keywords